The effect of bacteriophages T4 and HAP1 on in vitro melanoma migration

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Da̧browska, Krystyna ^a   Skaradziński, Grzegorz ^a   Jończyk, Paulina ^a   Kurzȩpa, Aneta ^a   Wietrzyk, Joanna ^a   Owczarek, Barbara ^a   Zaczek, Maciej ^a   Świtała Jeleń, Kinga ^a,b   Boratyński, Janusz ^a   Poźniak, Gryzelda ^c   Maciejewska, Magdalena ^a   Gárski, Andrzej ^a,d  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRONECTIN; LAMININ; LIPOPOLYSACCHARIDE; MATRIGEL; PROTEOGLYCAN;

ANIMAL; ARTICLE; BACTERIOPHAGE T4; CELL MOTION; DRUG COMBINATION; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BACTERIOPHAGE T4; CELL LINE, TUMOR; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; FIBRONECTINS; HUMANS; LAMININ; LIPOPOLYSACCHARIDES; MICE; PROTEOGLYCANS;

EID: 60349092548     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-13     Document Type: Article

References (24)

1. WHO Data and Statistics. World Health Organization [homepage on the Internet], WHO 2008 http://www.who.int/research/en/
2. Current clinical overview of cutaneious melanoma. M Lens, Br J Nurs 2008 17 300 305 18414292
3. World Alliance for Patient Safety "WHO Guidelines on hand hygiene in health care (Advanced Draft): A Summary". World Health Organization [homepage on the Internet], WHO 2005 http://www.who.int/patientsafety/events/05/ HH-en.pdf
4. WHO Health Topics, Antimicrobial Resistance (fact sheet 194, January 2002). World Health Organization [homepage on the Internet], http://www.who.int/topics/en/
5. Stalin's Forgotten Cure. R Stone, Science 2002 298 728 731 10.1126/science.298.5594.728 12399562
6. The prospect for bacteriophage therapy in Western medicine. CR Merril D Scholl SL Adhya, Nat Rev Drug Discov 2003 2 489 497 10.1038/nrd1111 12776223
7. Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections. A Sulakvelidze, Drug Discov Today 2005 10 807 809 10.1016/S1359-6446(05)03441-0 15970258
8. Phage Therapy: Bacteriophages as Nautural Self -Limiting Antibiotics. J Pizzorno M Murray, Churchill/Livingstone 2005
9. Phage therapy: facts and fiction. M Skurnik E Strauch, Int J Med Microbiol 2006 296 5 14 10.1016/j.ijmm.2005.09.002 16423684
10. Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. HW Smith MB Huggins KM Shaw, J Gen Microbiol 1987 133 1127 1135 3309178
11. Long-circulating bacteriophage as antibacterial agents. CR Merril B Biswas RM Carlton NC Jensen GJ Creed S Zullo S Adhya, Proc Natl Acad Sci USA 1996 93 3188 3192 8622911 10.1073/pnas.93.8.3188
12. The potential role of endogenous bacteriophages in controlling invading pathogens. A Gorski B Weber-Dabrowska, Cell Mol Life Sci 2005 62 511 519 10.1007/s00018-004-4403-6 15747058
13. Antitumour activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of β3 integrin signaling pathway. K Dabrowska A Opolski J Wietrzyk K Switala-Jelen J Boratynski A Nasulewicz L Lipinska A Chybicka M Kujawa M Zabel B Dolinska-Krajewska E Piasecki B Weber-Dabrowska J Rybka J Salwa E Wojdat M Nowaczyk A Gorski, Acta Virol 2004 48 241 248 15745047
14. Hoc protein regulates the biological effects of T4 phage in mammals. K Da̧browska M Zembala J Boratynski M Kujawa K Świtala-Jelen J Wietrzyk A Opolski K Szczaurska J Godlewska A Gorski, Arch Microbiol 2007 187 489 498 10.1007/s00203-007-0216-y 17294171
15. New insights into the possible role of bacteriophages in host defense and disease. A Gárski K Da̧rowska K Świtala-Jelẽ M Nowaczyk B Weber-Dabrowska J Boratynski J Wietrzyk A Opolski, Med Immunol 2003 2 2 12625836 10.1186/1476-9433-2-2
16. In adrenal glomerulosa cells, Angiotensin II inhibits proliferation by interfering with fibronectin-integrin signaling. M Otis S Campbell MD Payet N Gallo-Payet, Endocrinology 2008 149 3435 3445 10.1210/en.2008-0282 18388189
17. Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins. S Reiss M Sieber V Oberle A Wentzel P Spangenberg R Claus H Kolmar W Lösche, Platelets 2006 17 153 157 10.1080/09537100500436663 16702041
18. Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells. A Mitra J Chakrabarti A Chatterjee, J Environ Pathol Toxicol Oncol 2003 22 167 178 10.1615/JEnvPathToxOncol.v22.i3.20 14529092
19. Adhesion, migration and communication in melanocytes and melanoma. NK Haass KS Smalley L Li M Herlyn, Pigment Cell Res 2005 18 150 159 10.1111/j.1600-0749.2005.00235.x 15892711
20. Preparation of endotoxin-free bacteriophages. J Boratỹski D Syper B Weber-Dabrowska M Łusiak-Szelachowska G Poźniak A Gárski, Cell Mol Biol Lett 2004 9 253 259 15213806
21. MH Adams, Bacteriophages New York, Inter. Science Publ 2005
22. Structural studies of the O-specific polysaccharide of Hafnia alvei strain PCM 1206 lipopolysaccharide containing D-allothreonine. C Petersson T Niedziela W Jachymek L Kenne P Zarzecki C Lugowski, Eur J Biochem 1997 244 580 586 10.1111/j.1432-1033.1997.00580.x 9119027
23. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of procedure. O Westphal K Jann, Methods in Carbohydrate Chemistry Academic Press, Inc., New York, Whisler RL, 1965 5 83 91
24. Involvement of integrin alpha(v)beta(3) and cell adhesion molecule L1 in transendothelial migration of melanoma cells. EB Voura RA Ramjeesingh AM Montgomery CH Siu, Mol Biol Cell 2001 12 2699 2710 11553709